This Issue At A Glance

In a report from the Multicenter Uveitis Steroid Treatment (MUST) Trial, Friedman et al (p. 1571) analyzed the 2-year incidence of raised intraocular pressure (IOP) and optic nerve damage in patients who had noninfectious intermediate, posterior, or panuveitis and were randomized to receive either fluocinolone acetonide (FA) implants or standard systemic therapy. In this randomized, partially masked trial, eyes with FA implants (245 eyes of 129 patients) did worse than those assigned to standard therapy (234 eyes of 126 patients) in all measures. Implant eyes had a 4- to 5-fold greater (Read more...)

Full Story →